MYCO could be the next to run like MMEDMydecine MYCO London Stock Exchange (LSE) uplisting is coming soon. Just as MMED has seen the hype to a $660M+ market cap on an upcoming NASDAQ listing, MYCO's $44M market cap is about to do the same and increase mightily imho.
I made a lot of money here since IPO day, and I still hold MMED long, but there's plenty opportunities out there. MYCO has been quietly doing some big things, and there's room for multiple companies completing similar trials for a drug that could breakthrough modern medicine and change the way we forever look at mental health - especially anxiety, depression, ptsd and addiction.
In shrooms we trust.